Sunny Pharmtech Inc. (TPEX:6676)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.35
+0.20 (1.65%)
Aug 26, 2026, 1:49 PM CST

Sunny Pharmtech Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-325.13-302.05-156-63.32-170.24-174.79
Depreciation & Amortization
123.27123.53119.67118.01108.36103.12
Other Amortization
4.054.053.353.213.331.74
Loss (Gain) From Sale of Assets
0.130.13-0.080.080.09-
Asset Writedown & Restructuring Costs
---1.24--
Loss (Gain) From Sale of Investments
-28.82-27.06----
Stock-Based Compensation
1.121.481.3712.6313.074.17
Other Operating Activities
-7.260.350.89-0.5-3.660.59
Change in Accounts Receivable
3.99-15.227.01-27.5834.86-24.45
Change in Inventory
62.8343.35-26.45-25.125.6642.78
Change in Accounts Payable
-28.3-8.6-9.2513.79-10.816.52
Change in Unearned Revenue
52.0623.0523.3611.0512.93.68
Change in Other Net Operating Assets
-11.54-2.01-0.96-5.4113.312.29
Operating Cash Flow
-153.58-158.99-37.138.126.88-34.35
Operating Cash Flow Growth
---41.75%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-33.13-29.33-45.71-143.99-179.18-158.95
Sale of Property, Plant & Equipment
--0.08---
Sale (Purchase) of Intangibles
-0.99-4.8-3.77-1.21-16.11-1.57
Investment in Securities
57.6-4.11-36.0859.69-31.14-53.58
Other Investing Activities
4.050.070.27-0.354.810.31
Investing Cash Flow
27.53-38.17-85.22-85.85-221.63-213.79

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-14320-1403.28
Long-Term Debt Issued
---55339290
Total Debt Issued
791432055479293.28
Short-Term Debt Repaid
--20--190--
Long-Term Debt Repaid
--24.92-31.61-50.64-290.18-310.99
Total Debt Repaid
-188-44.92-31.61-240.64-290.18-310.99
Net Debt Issued (Repaid)
-10998.08-11.61-185.64188.82-17.71
Issuance of Common Stock
248.428.821.4281.32-252.7
Other Financing Activities
-----0.440.44
Financing Cash Flow
139.42106.9-10.2195.67188.38235.43

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
13.38-90.26-132.5347.92-6.37-12.71

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-186.71-188.32-82.81-105.88-152.3-193.31
Free Cash Flow Growth
------
Free Cash Flow Margin
-80.01%-74.43%-19.81%-24.69%-42.35%-80.21%
Free Cash Flow Per Share
-1.23-1.26-0.56-0.74-1.10-1.45
Levered Free Cash Flow
-66.78-98.68-46.2-91.48-118.38-157.65
Unlevered Free Cash Flow
-59.59-92.21-40.54-84.45-115.52-154.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
10.3610.369.0711.248.265.62
Cash Income Tax Paid
--0.350.30.5-0.01-0.02
Change in Working Capital
79.0540.58-6.3-33.2575.9230.82